---
figid: PMC7826465__CAM4-10-337-g007
figtitle: Molecular mechanism in the suppression of ovarian cancer malignancy by lidocaine
organisms:
- NA
organisms_ner:
- NA
pmcid: PMC7826465
filename: CAM4-10-337-g007.jpg
figlink: pmc/articles/PMC7826465/figure/cam43621-fig-0007/
number: F7
caption: Schematic representation of the molecular mechanism in the suppression of
  ovarian cancer malignancy by lidocaine. Ovarian cancer cells expressing high NaV1.5
  level present strong capacity of intraperitoneally implanted metastasis. Lidocaine
  binding with NaV1.5 blocks the activation of FAK/Paxillin signaling pathway, inhibits
  the proliferation and metastasis, and decreases cisplatin resistance of ovarian
  cancer cells. The voltage‐gated sodium channels (VGSCs) blocker, tetrodotoxin (TTX),
  or FAK inhibitor (FAKi) reduces ovarian cancer malignancy by inactivating FAK/Paxillin
  signaling pathway
papertitle: Lidocaine inhibits the metastatic potential of ovarian cancer by blocking
  NaV1.5‐mediated EMT and FAK/Paxillin signaling pathway.
reftext: Chang Liu, et al. Cancer Med. 2021 Jan;10(1):337-349.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9338847
figid_alias: PMC7826465__F7
figtype: Figure
redirect_from: /figures/PMC7826465__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7826465__CAM4-10-337-g007.html
  '@type': Dataset
  description: Schematic representation of the molecular mechanism in the suppression
    of ovarian cancer malignancy by lidocaine. Ovarian cancer cells expressing high
    NaV1.5 level present strong capacity of intraperitoneally implanted metastasis.
    Lidocaine binding with NaV1.5 blocks the activation of FAK/Paxillin signaling
    pathway, inhibits the proliferation and metastasis, and decreases cisplatin resistance
    of ovarian cancer cells. The voltage‐gated sodium channels (VGSCs) blocker, tetrodotoxin
    (TTX), or FAK inhibitor (FAKi) reduces ovarian cancer malignancy by inactivating
    FAK/Paxillin signaling pathway
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Lidocaine
  - TTX
  - Cisplatin
  - Ovarian cancer malignancy
---
